- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| Do | Imac Holdings-Aktie fällt auf 52-Wochen-Tief von 0,96 US-Dollar | 1 | Investing.com Deutsch | ||
| Do | Imac Holdings Stock Hits 52-Week Low at $0.96 Amidst Steep Decline | 1 | Investing.com | ||
| 17.01. | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 20.12.24 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.12.24 | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 22.11.24 | IMAC Holdings receives non-compliance notice from Nasdaq | 2 | Seeking Alpha | ||
| 22.11.24 | IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q | 113 | GlobeNewswire (Europe) | FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing... ► Artikel lesen | |
| 22.11.24 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.11.24 | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 14.11.24 | Imac Holdings-Aktie erreicht 52-Wochen-Tief bei 1,02 US-Dollar | 2 | Investing.com Deutsch | ||
| 14.11.24 | Imac Holdings stock hits 52-week low at $1.02 | 1 | Investing.com | ||
| 14.11.24 | IMAC Holdings, Inc.: IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c) | 85 | GlobeNewswire (Europe) | FRANKLIN, TN, Nov. 14, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it has received an exception from the Listing Qualifications Staff... ► Artikel lesen | |
| 13.11.24 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.10.24 | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.09.24 | IMAC Holdings welcomes Jeffrey Busch to its Board of Directors | 2 | Investing.com | ||
| 25.09.24 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09.24 | Imac Holdings stock hits 52-week low at $1.2 amid market challenges | 1 | Investing.com | ||
| 19.09.24 | IMAC Holdings, Inc.: IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology | 1 | GlobeNewswire (USA) | ||
| 13.09.24 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.08.24 | IMAC Holdings receives notification of deficiency from Nasdaq | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 1,170 | +1,56 % | Plus Therapeutics Announces Renewal Of Master Services Agreement With Telix | CANBERA (dpa-AFX) - Plus Therapeutics (PSTV) announced the renewal of its Master Services Agreement with Telix IsoTherapeutics Group. The MSA secures supply of cGMP Re-186, the radioisotope... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
| LIFEWARD | 1,530 | -0,65 % | Lifeward Ltd.: Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities | MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), today issued an open letter from Larry Jasinski, Chief Executive... ► Artikel lesen | |
| EKSO BIONICS | 0,630 | +1,29 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Announces Third Quarter 2024 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today... ► Artikel lesen | |
| IMUNON | 0,910 | -1,09 % | Imunon, Inc.: IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer | Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001 Vertical integration of major components assures a high-quality, commercially viable future... ► Artikel lesen | |
| ROCKWELL MEDICAL | 2,060 | -1,25 % | ROUNDUP/Aktien New York: Erneute Dow-Verluste - Nasdaq-Rally pausiert | NEW YORK (dpa-AFX) - An den US-Börsen bahnt sich am Dienstag für den Dow Jones Industrial der neunte Schwächetag in Folge an. Anders als zuletzt wird der US-Leitindex dabei aber von den anderen US-Indizes... ► Artikel lesen | |
| AVINGER | 0,556 | 0,00 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 17,900 | 0,00 % | Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data | WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 3,180 | -0,62 % | SINTX Technologies, Inc.: SINTX Technologies Provides Positive Strategic Business Update for Q3 2024 | Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an advanced ceramics company that develops and commercializes materials, components... ► Artikel lesen | |
| AETHLON MEDICAL | 0,610 | -3,17 % | Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update | Achieves Key Milestone with Enrollment of First Two Patients in the Safety, Feasibility, and Dose Finding Study of Aethlon's Hemopurifier® in Patients with Solid... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | 0,00 % | Stagezero Life Sciences Ltd (2): Stagezero loses $1.43-million (U.S.) in nine months | ||
| NEURONETICS | 2,240 | 0,00 % | Neuronetics Provides Business Update and Issues 2025 Guidance | Preliminary unaudited fourth quarter and full year revenue 2024 was $22.1 and $74.5, respectivelyClosed acquisition of Greenbrook TMS effective as of December 9, 2024Expects full year 2025 pro forma... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| HVIVO | 0,204 | -0,97 % | hVIVO secures largest standalone lab contract to date |
IMAC HOLDINGS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,790 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.
